作者:
Han,S. [1]
;
Akiyama,T.E. [2]
;
Previs,S.F. [3]
;
Herath,K. [4]
;
Roddy,T.P. ;
Jensen,K.K. ;
Guan,H.-P. ;
Murphy,B.A. ;
McNamara,L.A. ;
Shen,X. ;
Strapps,W. ;
Hubbard,B.K. ;
Pinto,S. ;
Li,C. ;
Li,J.
作者单位:
Division of RNA Therapeutics, Merck Sharp and Dohme Corp., Whitehouse Station, NJ, United States
[1]
Division of Cardiovascular Disease, Merck Sharp and Dohme Corp., Whitehouse Station, NJ, United
[2]
Division of Pharmacology, Merck Sharp and Dohme Corp., Whitehouse Station, NJ, United States
[3]
Division of Diabetes Research, Merck Sharp and Dohme Corp., Whitehouse Station, NJ, United States
[4]
发布时间
2013-12-19